Stocks and Investing
Stocks and Investing
Tue, May 14, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, May 13, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Wasserman Upgraded (BLFS) to Strong Buy and Held Target at $25 on, May 13th, 2024
Robert Wasserman of Benchmark, Upgraded "BioLife Solutions, Inc." (BLFS) to Strong Buy and Held Target at $25 on, May 13th, 2024.
Robert has made no other calls on BLFS in the last 4 months.
There is 1 other peer that has a rating on BLFS. Out of the 1 peers that are also analyzing BLFS, 0 agree with Robert's Rating of Hold.
This is the rating of the analyst that currently disagrees with Robert
- Matthew Stanton of "Jefferies" Initiated at Strong Buy and Held Target at $22 on, Thursday, April 4th, 2024
Contributing Sources